Intra- and Interrater Reliability of Quantitative Ultrasound Assessment of Gastric Content in Term Parturients Before Elective Caesarean Delivery

Sponsor
Samuel Lunenfeld Research Institute, Mount Sinai Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05946447
Collaborator
(none)
30
1
1
5
6

Study Details

Study Description

Brief Summary

The presence of solid food or fluid residue in the stomach is always a major concern when patients require medical procedures under sedation or general anesthesia, due to the high risk of pulmonary aspiration of the stomach contents. This is especially important in emergency procedures, when a fasting period could not be observed. Pulmonary aspiration of gastric content is a serious perioperative complication of obstetric anesthesia, and it is associated with morbidity and mortality. Information from a bedside ultrasound assessment of the stomach may be a very useful resource to decide whether it's safe to proceed, cancel or delay a surgical procedure. The ultrasound assessment of the stomach content has shown to be very feasible and practical in non-pregnant patients. However, it has not been determined whether the competence reached by anesthesiologists in non-pregnant subjects can be transferred to the obstetric population, especially in term pregnant patients where it could be difficult to identify the stomach because of the presence of the gravid uterus. Although quantitative assessment of the gastric antrum cross-sectional area in terms of intra- and interrater reliability has been evaluated in non-pregnant adults, it remains to be evaluated in pregnant patients. Furthermore, it has not been determined whether the performance of novice operators is comparable to expert operators in the gastric quantitative assessment. This study aims to determine whether trained anesthesiologists can reliably assess the stomach content of pregnant patients by ultrasound, evaluating the inter- and intra-rater reliability of quantitative gastric ultrasound in term pregnant patients comparing anesthesiologists of different level of expertise. The investigators hypothesize a substantial to almost perfect agreement in the intra- and interrater reliability of the antral cross-sectional area among raters in term pregnant patients scheduled for elective cesarean delivery.

Condition or Disease Intervention/Treatment Phase
  • Device: Ultrasound
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Intra- and Interrater Reliability of Quantitative Ultrasound Assessment of Gastric Content in Term Parturients Before Elective Caesarean Delivery
Anticipated Study Start Date :
Jul 1, 2023
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Gastric Ultrasound

Ultrasound measurements of the antrum will be recorded.

Device: Ultrasound
The gastric antrum will be scanned using ultrasound.
Other Names:
  • Gastric Ultrasound
  • Outcome Measures

    Primary Outcome Measures

    1. Antral cross-sectional area (supine position) [5 minutes]

      The cross-sectional area (in centimeters squared) of the antrum will be measured with the patient in supine position, using the ultrasound machine. Measurements will be done 3 times, by 2 investigators.

    2. Antral cross-sectional area (right lateral decubitus) [5 minutes]

      The cross-sectional area (in centimeters squared) of the antrum will be measured with the patient in right lateral decubitus position, using the ultrasound machine. Measurements will be done 3 times, by 2 investigators.

    Secondary Outcome Measures

    1. Intra-rater reliability calculation [5 minutes]

      Intra-rater reliability will be calculated using the 3 measurements, for each rater.

    2. Inter-rater reliability calculation [5 minutes]

      Inter-rater reliability will be calculated using the 3 measurements, between raters.

    3. Grading of stomach contents [5 minutes]

      Grading scale: grade 0 means no gastric contents are visualized in supine and the right lateral decubitus, grade 1 means gastric contents are visualized in right lateral decubitus but not in supine decubitus, and grade 2 means gastric contents are visualized in both positions

    4. Gastric volume (supine position) [5 minutes]

      Gastric volume (ml) will be estimated using the antral cross-sectional area obtained with the patient in supine position

    5. Gastric volume (right lateral decubitus) [5 minutes]

      Gastric volume (ml) will be estimated using the antral cross-sectional area obtained with the patient in right lateral decubitus.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 50 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • non-laboring term pregnant women scheduled for cesarean delivery under neuraxial anesthesia

    • ≥37 weeks gestational age

    • ≥18 years of age

    • ASA physical status II-III

    • weight 50 to 120 kg

    • height ≥150 cm

    • ability to understand the rationale of the study evaluations.

    Exclusion Criteria:
    • multiple pregnancy

    • known (reported by the study subject) anomalous anatomy of the upper gastrointestinal tract

    • previous surgical procedures on the esophagus, stomach or upper abdomen

    • patients not following our institutional fasting instructions (8 hours after a meal and 2 hours for clear liquids)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Mount Sinai Hospital Toronto Ontario Canada M5G1X5

    Sponsors and Collaborators

    • Samuel Lunenfeld Research Institute, Mount Sinai Hospital

    Investigators

    • Principal Investigator: Cristian Arzola, MD, MOUNT SINAI HOSPITAL

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Samuel Lunenfeld Research Institute, Mount Sinai Hospital
    ClinicalTrials.gov Identifier:
    NCT05946447
    Other Study ID Numbers:
    • 23-02
    First Posted:
    Jul 14, 2023
    Last Update Posted:
    Jul 14, 2023
    Last Verified:
    Jun 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Samuel Lunenfeld Research Institute, Mount Sinai Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 14, 2023